| Jul 16 |
Gilead to Highlight Landmark Progress in Research Across HIV Prevention, Treatment and Cure Programs at AIDS 2024
|
| Jul 15 |
The 3 Most Undervalued Nasdaq 100 Stocks to Buy in July 2024
|
| Jul 14 |
3 Dividend Growth Stocks to Buy and Hold
|
| Jul 13 |
The 7 Most Undervalued Healthcare Stocks to Buy in July 2024
|
| Jul 11 |
3 Underappreciated Stocks About to Break Their Chains
|
| Jul 11 |
Is Gilead Sciences (NASDAQ:GILD) A Risky Investment?
|
| Jul 9 |
7 Cheap Biotech Stocks With Major Upside Potential
|
| Jul 8 |
Gilead Gets Analyst Upgrade on 'Outstanding' HIV Treatment Data
|
| Jul 8 |
This Domino's Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
|
| Jul 8 |
Gilead (GILD) Loses 17.6% YTD: How Should You Play the Stock?
|
